Hotchkis & Wiley Capital Management’s Phibro Animal Health PAHC Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-346,360	Closed	-$5.81M	–	526
2024 Q2	$5.81M	Sell	346,360 -167,970	-33%	-$2.7M	0.02%	366
2024 Q1	$6.65M	Sell	514,330 -26,600	-5%	-$319K	0.02%	336
2023 Q4	$6.26M	Buy	540,930 +145,450	+37%	+$1.64M	0.02%	367
2023 Q3	$5.05M	Hold	395,480	–	–	0.02%	383
2023 Q2	$5.42M	Buy	395,480 +36,740	+10%	+$526K	0.02%	353
2023 Q1	$5.5M	Buy	358,740 +900	+0.3%	+$13.8K	0.02%	344
2022 Q4	$4.8M	Buy	357,840 +233,960	+189%	+$3.14M	0.02%	367
2022 Q3	$1.65M	Buy	+123,880	New	+$2.14M	0.01%	488
2017 Q2	–	Sell	-136,900	Closed	-$3.85M	–	176
2017 Q1	$3.85M	Sell	136,900 -221,380	-62%	-$6.25M	0.02%	146
2016 Q4	$10.5M	Sell	358,280 -60,420	-14%	-$1.65M	0.04%	135
2016 Q3	$11.4M	Buy	+418,700	New	+$9.47M	0.05%	134

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Hotchkis & Wiley Capital Management's PAHC Position: Q3 2024 in Review

Hotchkis & Wiley Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2024, closing a stake of 346,360 shares — an estimated $5.81M sold.

Hotchkis & Wiley Capital Management first reported a position in PAHC in Q3 2016 and held it in 11 quarters. The position peaked at $11.4M in Q3 2016. 147 funds tracked by Wall St. Rank hold PAHC as of Q3 2024.

Hotchkis & Wiley Capital Management reported no remaining Phibro Animal Health position as of Q3 2024 after selling out during the quarter.
Hotchkis & Wiley Capital Management sold 346,360 Phibro Animal Health shares in Q3 2024, an estimated $5.81M.
Hotchkis & Wiley Capital Management first reported a position in Phibro Animal Health in Q3 2016 and held it in 11 quarters.
Hotchkis & Wiley Capital Management's Phibro Animal Health position peaked at $11.4M in Q3 2016.
147 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2024.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.